Benzo[a]pyrene-enhanced mutagenesis by asbestos in the lung of λ-lacI transgenic rats

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 553, Issue 1-2, 2004, Pages 79-90

  Loli, P ^a   Topinka, J ^b,c   Georgiadis, P ^a   Dusinska M ^d   Hurbankova M ^d   Kovacikova Z ^d   Volkovova K ^d   Wolff, T ^b   Oesterle, D ^b   Kyrtopoulos, S A ^a  

^a INSTITUTE OF BIOLOGY   (Greece)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c INSTITUTE OF EXPERIMENTAL MEDICINE   (Czech Republic)

^d INST OF PREV AND CLINICAL MEDICINE   (Slovakia)

Author keywords

5 bromo 2 deoxyuridine; alveolar macrophages; AM; B a P; benzo a pyrene; BrdU; CM; control mutants; dimethylsulphoxide; DMSO; malondialdehyde; MDA; MF; mutation frequency; PAH; PFU; plaque forming unit; polycyclic aromatic hydrocarbons; RAL

Indexed keywords

AMOSITE; ASBESTOS; BENZO[A]PYRENE; CARCINOGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ASBESTOSIS; CANCER RISK; CHEMICAL CARCINOGENESIS; CHEMICAL MUTAGENESIS; CONFERENCE PAPER; CONTROLLED STUDY; LUNG CANCER; LUNG CARCINOGENESIS; MALE; MITOGENESIS; MUTATION RATE; NONHUMAN; OCCUPATIONAL CARCINOGENESIS; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; RAT; SMOKING;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; ASBESTOS; ASBESTOS, AMOSITE; BENZO(A)PYRENE; DNA ADDUCTS; FEMALE; INSTILLATION, DRUG; LUNG; MALE; MALONDIALDEHYDE; MINERAL FIBERS; MUTAGENS; RATS; RATS, INBRED F344; RATS, WISTAR; REPRESSOR PROTEINS;

NICOTIANA TABACUM;

EID: 3342998511     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2004.06.025     Document Type: Conference Paper

References (14)

1. Jarvholm B., Larsson S., Hagberg S., Olling S., Ryd W., Toren K. Quantitative importance of asbestos as a cause of lung cancer in Swedish industrial city - a case-referent study. Eur. Resp. J. 6:1993;1271-1275
2. Selikoff I.J., Hammond E.C., Churg J. Asbestos exposure, smoking, and neoplasia. J. Am. Med. Assoc. 204:1968;106-112
3. Saracci R. Asbestos and lung cancer: an analysis of the epidemiological evidence on the asbestos smoking interaction. Int. J. Cancer. 20:1977;323-331
4. Nelson H.H., Kelsey K.T. The molecular epidemiology of asbestos and tobacco in lung cancer. Oncogene. 21(48):2002;7284-7288
5. Kimizuka G., Azuma M., Ishibashi M. Co-carcinogenic effect of chrysotile and amosite asbestos with benzo[a]pyrene in the lung of hamsters. Acta Pathol. Jpn. 43:1993;149-153
6. Gerde P., Muggenburg B.A., Henderson R.F., Dahl A.R. Particle-associated hydrocarbons and lung cancer: the correlation between cellular dosimetry and tumor distribution. Cell Biol. 85:1994;337-344
7. J.M. Davis, Mixed fibrous and non-fibrous dust exposures and interactions between agents in fibre carcinogenesis, in: A.B. Kane, P. Boffetta, R. Saracci, J.D. Wilbourn (Eds.), Mechanisms of Fibre Carcinogenesis, IARC Scientific Publications, No. 140, IARC, Lyon, 1996, pp. 127-135.
8. Gupta R.C. Non-random binding of the carcinogen N-hydroxy-2-acetylamino- fluorene to repetitive sequences of rat liver DNA in vivo. Proc. Natl. Acad. Sci. U.S.A. 81:1984;6943-6947
9. Topinka J., Andrae U., Schwarz L.R., Wolff T. Cyproterone acetate generates DNA adducts in rat liver and in primary rat hepatocyte cultures. Carcinogenesis. 14:1993;423-427
10. Ellwart J., Dormer P. Effect of 5-fluoro-2′-bromo-deoxyuridine on 5-bromo-2′-deoxyuridine (BrdUrd) incorporation into DNA measured by a monoclonal BrdU antibody and by the BrdUrd/Hoechst quenching effect. Cytometry. 6:1985;513-520
11. Binkova B., Hubalek F., Sram R.J. Stability of benzo[a]pyrene DNA adducts in rat tissues during their long-term storage at -20 or -80°C. Mutat. Res. 371:1996;229-235
12. Shane B.S., Lockhart A.M., Winston G.W., Tindall K.R. Mutant frequency of lacI in transgenic mice following benzo[a]pyrene treatment and partial hepatectomy. Mutat. Res. 377:1997;1-11
13. Chramostová K., Vondráèek J., Šindelá øová L., Vojtìšek B., Kozubík A., Machala M. Polycyclic aromatic hydrocarbons modulate cell proliferation in rat hepatic epithelial stem-like WB-F344 cells. Toxocol. Appl. Pharmacol. 196:2004;136-148
14. Heddle J.A., Swinger R.R. Risk estimation from somatic mutation assays. Mutat. Res. 365:1996;107-117